ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
NiH-Catalyzed Enantio- and Regioselective Hydroselenylation of Unactivated Alkenes.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chiral alkyl selenides are valuable motifs in medicinal chemistry and redox-active molecular design, yet enantioselective hydroselenylation of unactivated alkenes remains challenging due to limited control over regio- and enantioselectivity. Here, we report nickel-hydride-catalyzed enantio- and regioselective hydroselenylation of unactivated alkenes directed by native amide groups using readily available diselenides. The method accommodates both terminal and internal alkenes as well as both aryl and alkyl diselenides, exhibiting broad functional-group tolerance and delivering structurally diverse chiral aliphatic selenides with high regio- and enantioselectivity under mild conditions. Mechanistic studies support enantiodetermining hydronickelation followed by single-electron diselenide activation and selective capture of the selenium radical by the chiral alkyl-nickel intermediate. This work establishes a general platform for asymmetric C─Se bond formation through the integration of NiH catalysis and radical selenium transfer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.